Beta3-adrenergic receptors (β3AR) have emerged as significant players in the management of heart failure (HF) and cardiac function. Traditionally, beta-adrenergic receptors have been associated ...

Major beta blocker mortality trials in chronic heart failure: a critical review. Heart. 1999;82(suppl 4):IV14 IV22. Altered adrenergic receptor sensitivity due to polymorphic variation.

Lopez-Sendon J, Swedberg K, McMurray J et al. Expert consensus document on β-adrenergic receptor blockers. Eur. Heart. J. 25(15), 1341–1362 (2004). Brodde OE. β-1 and β-2 adrenoceptor ...

Alpha-1 adrenergic receptors (α1-ARs) play a significant role in the regulation of cardiovascular function, particularly in conditions such as heart failure and myocardial infarction (MI).

There are three beta-adrenergic receptors—β1, β2, and β3—that perform numerous functions across the body, primarily to relay signals from the sympathetic nervous system to various tissues.

Atenolol blocks beta-1 receptors, which are present on the heart. This medication is a beta-blocker, prescribed for high blood pressure and to prevent heart pain and recurrence of heart attacks.

Beta-blockers lower heart rate and blood pressure and help ... They're both beta-blockers, which means they block beta-adrenergic receptors in the body so that other molecules can't bind to ...

angiotensin receptor blockers, sacubitril/valsartan (Entresto, Novartis), continued beta-adrenergic blockade, aldosterone antagonists and HMG-CoA reductase inhibitors. Early antithrombotic ...

Metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent ... By blocking catecholamine-induced increases in heart rate, in velocity and extent of myocardial ...

Timolol maleate is a beta 1 and beta 2 (non-selective) adrenergic receptor blocking agent that ... bronchospasm, heart failure). Aphakic maculopathy (rare).